Pfizer shelves haemophilia gene therapy Beqvez amid low demand
Pfizer said resources will be directed to its other haemophilia gene therapy Hympavzi.
Cytiva Pipe dream to pipeline WP 3
FDA grants fast track status to Rznomics’ RZ-001 for HCC
SmartCella gains rights to advance cell therapy research for Parkinson’s
Italian charity seeks EMA approval for rescued gene therapy
Thermo Fisher continues viral vector withdrawal; lays off 300 employees
Rentschler closes UK cell and gene therapy facility and does a pivot to biologics
NHS England to offer Casgevy for sickle cell disease patients
Leveragen and Moonlight Bio unite for T-cell therapy development
